Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04700696 · ClinicalTrials.gov registry record · NA
Enhancing Permanency in Children and Families
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT04700696: Completed NA study, sponsored by Ohio State University.
NCT04700696 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04700696, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
The Enhancing Permanency in Children and Families (EPIC) program is a collaborative effort between the Ohio State University College of Social Work, two county offices of the Ohio Department of Job and Family Services, two juvenile courts and local behavioral health agencies. The goal of EPIC is to use three evidence-based and evidence-informed practices to reduce abusive and neglectful parenting, reduce addiction severity in parents, and improve permanency outcomes for families involved with the child welfare system due to substance abuse.
Primary Outcome
Measures: 1) Child welfare case open date; 2) UNCOPE assessment screening date Analyses: We will use T-tests to estimate mean differences in the length of time from entry into child welfare and SUD screening for EPIC participants in comparison to Ohio START and treatment as usual.
Interventions
- BEHAVIORAL Peer Recovery Support
- BEHAVIORAL Family Treatment Drug Court with Medications for Opioid Use Disorders (MOUD)
- BEHAVIORAL Relational Skill Building based on the Nurturing Parenting Program (NPP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT04700696 record still lists
NCT04700696 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which Peer Recovery Support is the first listed.
NCT04700696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04700696 about?
NCT04700696 is a clinical study titled "Enhancing Permanency in Children and Families". The Enhancing Permanency in Children and Families (EPIC) program is a collaborative effort between the Ohio State University College of Social Work, two county offices of the Ohio Department of Job and Family Services, two juvenile courts and local behavioral health agencies. The goal of EPIC is to ...
What is the current status of trial NCT04700696?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2017-10-01. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT04700696?
The interventions under investigation include: Peer Recovery Support (BEHAVIORAL), Family Treatment Drug Court with Medications for Opioid Use Disorders (MOUD) (BEHAVIORAL), Relational Skill Building based on the Nurturing Parenting Program (NPP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04700696?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04700696's enrollment target sits among peer trials
117 807th of 2000 higher than 1,193 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI